These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36156735)
1. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis. Kisaoglu H; Baba O; Kalyoncu M Pediatr Nephrol; 2023 Apr; 38(4):1167-1175. PubMed ID: 36156735 [TBL] [Abstract][Full Text] [Related]
2. Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort. Hao Y; Oon S; Ji L; Gao D; Fan Y; Geng Y; Zhang X; Li G; Morand EF; Nikpour M; Zhang Z Clin Rheumatol; 2022 Feb; 41(2):357-366. PubMed ID: 34595670 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus. Na Nakorn K; Piyaphanee N; Sukharomana M; Pinpatanapong R; Charuvanij S Clin Rheumatol; 2023 Jun; 42(6):1655-1664. PubMed ID: 36780064 [TBL] [Abstract][Full Text] [Related]
4. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus. Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306 [TBL] [Abstract][Full Text] [Related]
5. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus. Piga M; Floris A; Cappellazzo G; Chessa E; Congia M; Mathieu A; Cauli A Arthritis Res Ther; 2017 Nov; 19(1):247. PubMed ID: 29126432 [TBL] [Abstract][Full Text] [Related]
6. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus. Kikuchi J; Hanaoka H; Saito S; Oshige T; Hiramoto K; Kaneko Y; Takeuchi T Rheumatology (Oxford); 2022 Aug; 61(9):3777-3791. PubMed ID: 35015824 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE. Cody EM; Wilson BE; Ogbu EA; Huggins JL; Chen C; Qiu T; Ting TV; Flores F; Huang B; Brunner HI Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37253553 [TBL] [Abstract][Full Text] [Related]
8. Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study. Fan C; Yang T; Zheng S; Liao X; Xie R; Chen S; Li J Front Immunol; 2024; 15():1423035. PubMed ID: 38947321 [TBL] [Abstract][Full Text] [Related]
9. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. Golder V; Kandane-Rathnayake R; Huq M; Nim HT; Louthrenoo W; Luo SF; Wu YJ; Lateef A; Sockalingam S; Navarra SV; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Lau CS; Li ZG; Hoi A; Nikpour M; Morand EF; Lancet Rheumatol; 2019 Oct; 1(2):e95-e102. PubMed ID: 38229349 [TBL] [Abstract][Full Text] [Related]
10. Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage. Floris A; Piga M; Perra D; Chessa E; Congia M; Mathieu A; Cauli A Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1794-1799. PubMed ID: 31600023 [TBL] [Abstract][Full Text] [Related]
11. Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus. Morand EF; Abreu G; Furie RA; Golder V; Tummala R Ann Rheum Dis; 2023 May; 82(5):639-645. PubMed ID: 36690388 [TBL] [Abstract][Full Text] [Related]
12. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission. Zen M; Iaccarino L; Gatto M; Saccon F; Larosa M; Ghirardello A; Punzi L; Doria A Ann Rheum Dis; 2018 Jan; 77(1):104-110. PubMed ID: 28970217 [TBL] [Abstract][Full Text] [Related]
13. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study. Golder V; Kandane-Rathnayake R; Li N; Louthrenoo W; Chen YH; Cho J; Lateef A; Hamijoyo L; Luo SF; Wu YJ; Navarra SV; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Goldblatt F; Oon S; O'Neill S; Ng K; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Lau CS; Hoi A; Nikpour M; Morand EF; Lancet Rheumatol; 2024 Jun; ():. PubMed ID: 38876129 [TBL] [Abstract][Full Text] [Related]
14. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. Smith EMD; Tharmaratnam K; Al-Abadi E; Armon K; Bailey K; Brennan M; Ciurtin C; Gardner-Medwin J; Haslam KE; Hawley D; Leahy A; Leone V; Malik G; McLaren Z; Pilkington C; Ramanan AV; Rangaraj S; Ratcliffe A; Riley P; Sen E; Sridhar A; Wilkinson N; Hedrich CM; Jorgensen A; Beresford MW Rheumatology (Oxford); 2022 Aug; 61(8):3378-3389. PubMed ID: 34894234 [TBL] [Abstract][Full Text] [Related]